Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.10
edited by Sarantis Dimitriadis
on 2022/06/07 10:20
Change comment: There is no comment for this version
To version 11.3
edited by Sarantis Dimitriadis
on 2023/12/08 12:59
Change comment: There is no comment for this version

Summary

Details

Page properties
Parent
... ... @@ -1,1 +1,1 @@
1 -Living Lab Business Model.WebHome
1 +Living Lab Business and Governance Model.WebHome
Content
... ... @@ -7,7 +7,7 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 -:
10 +:
11 11  
12 12  * (((
13 13  (% lang="en-US" %)**Non-professional end users:**
... ... @@ -17,7 +17,7 @@
17 17  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
18 18  )))
19 19  
20 -:
20 +:
21 21  
22 22  * (((
23 23  (% lang="en-US" %)**Professional end users**
... ... @@ -29,12 +29,12 @@
29 29  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
30 30  )))
31 31  
32 -:
32 +:
33 33  
34 34  (% class="western" lang="en-GB" %)
35 35  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
36 36  
37 -:
37 +:
38 38  
39 39  * (((
40 40  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
... ... @@ -50,7 +50,7 @@
50 50  * (% lang="en-US" %)Pharmaceutical companies
51 51  )))
52 52  
53 -:
53 +:
54 54  
55 55  * (((
56 56  (% lang="en-GB" %)
... ... @@ -67,7 +67,7 @@
67 67  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
68 68  )))
69 69  
70 -:
70 +:
71 71  
72 72  * (((
73 73  (% lang="en-GB" %)
... ... @@ -82,7 +82,7 @@
82 82  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
83 83  )))
84 84  
85 -:
85 +:
86 86  
87 87  * (((
88 88  (% lang="en-GB" %)
... ... @@ -91,7 +91,7 @@
91 91  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
92 92  )))
93 93  
94 -:
94 +:
95 95  
96 96  * (((
97 97  (% lang="en-GB" %)
... ... @@ -104,256 +104,108 @@
104 104  :
105 105  
106 106  (% class="western" lang="en-GB" %)
107 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
107 +Classification approaches of non-professional end users commonly acting as a primary study participant in a health and wellbeing living lab research project.
108 108  
109 -(% style="margin-left:auto; margin-right:auto" %)
110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)(((
111 -(% class="western" lang="en-GB" style="text-align:center" %)
112 -(% lang="en-US" %)**Age or age group**
113 -)))
114 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
109 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
115 115  (% lang="en-US" %)Specific age range
116 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
117 117  
118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
119 119  (% class="western" %)
120 120  
121 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
122 122  (% class="western" %)
123 123  
124 124  )))
125 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
124 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
126 126  (% class="western" lang="en-GB" %)
127 -(% lang="en-US" %)Elderly
128 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
126 +(% lang="en-US" %)Healthy
127 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
129 129  (% class="western" lang="en-GB" %)
130 -(% lang="en-US" %)Adults
131 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
132 -(% class="western" lang="en-GB" %)
133 -(% lang="en-US" %)Youth
134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
135 -(% class="western" lang="en-GB" %)
136 -(% lang="en-US" %)Children
137 -)))
138 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
139 -(% class="western" %)
140 140  
141 -)))
142 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
143 -(% class="western" lang="en-GB" style="text-align:center" %)
144 -(% lang="en-US" %)**Health status**
145 -)))
146 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
130 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
147 147  (% class="western" lang="en-GB" %)
148 -(% lang="en-US" %)Healthy
149 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
150 -(% class="western" lang="en-GB" %)
151 -(% lang="en-US" %)Patient
152 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
153 -(% class="western" lang="en-GB" %)
154 -(% lang="en-US" %)Rehabilitant
155 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
156 -(% class="western" lang="en-GB" %)
157 -(% lang="en-US" %)Recovered/Survivor
158 -)))
159 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
160 -(% class="western" %)
161 161  
162 -)))
163 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
164 -(% class="western" lang="en-GB" style="text-align:center" %)
165 -(% lang="en-US" %)**A specific disease, disorder or disability**
166 -)))
167 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
168 168  (% class="western" lang="en-GB" %)
169 -(% lang="en-US" %)ADHD
170 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
171 -(% class="western" lang="en-GB" %)
172 -(% lang="en-US" %)Dementia
173 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
174 -(% class="western" lang="en-GB" %)
175 -(% lang="en-US" %)Parkinsons’ disease
176 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
177 -(% class="western" lang="en-GB" %)
178 -(% lang="en-US" %)Loneliness and Social Isolation
179 -)))
180 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
181 -(% class="western" lang="en-GB" %)
182 -(% lang="en-US" %)Autism
183 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
184 -(% class="western" lang="en-GB" %)
185 -(% lang="en-US" %)Down syndrome
186 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
187 -(% class="western" lang="en-GB" %)
188 -(% lang="en-US" %)Physical disability
189 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
190 -(% class="western" lang="en-GB" %)
191 -(% lang="en-US" %)Mental health
192 -)))
193 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
194 -(% class="western" lang="en-GB" %)
195 -(% lang="en-US" %)Cardiovascular disease
196 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
197 -(% class="western" lang="en-GB" %)
198 -(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
199 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
200 -(% class="western" lang="en-GB" %)
201 -(% lang="en-US" %)Sleep apnea/apnea
202 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
203 -(% class="western" lang="en-GB" %)
204 -(% lang="en-US" %)Mild cognitive impairment
205 -)))
206 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
207 -(% class="western" lang="en-GB" %)
208 -(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
209 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
210 -(% class="western" lang="en-GB" %)
211 -(% lang="en-US" %)Language disability
212 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
213 -(% class="western" lang="en-GB" %)
214 -(% lang="en-US" %)Substance abuse (drugs, alcohol)
215 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
216 -(% class="western" lang="en-GB" %)
217 -(% lang="en-US" %)Multiple sclerosis
218 -)))
219 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
220 -(% class="western" lang="en-GB" %)
221 -(% lang="en-US" %)Cognitive disorder (mild, major)
222 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
223 -(% class="western" lang="en-GB" %)
224 -(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
225 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
226 -(% class="western" lang="en-GB" %)
227 -(% lang="en-US" %)Trauma patient
228 -
229 -(% class="western" lang="en-GB" %)
230 -(% lang="en-US" %)(e.g., a spinal cord injury)
231 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
232 -(% class="western" lang="en-GB" %)
233 -(% lang="en-US" %)Neurodegenerative diseases
234 -)))
235 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
236 -(% class="western" %)
237 237  
238 238  )))
239 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
240 -(% class="western" lang="en-GB" style="text-align:center" %)
241 -(% lang="en-US" %)**Clients of a specific service**
242 -)))
243 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
137 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
138 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Schizophrenia|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease
139 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Post-Stroke Patients with Moving or Linguistic Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Sleep Disorders: e.g., Apnea, Hypopnea|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
140 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
141 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
142 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
143 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
244 244  (% class="western" lang="en-GB" %)
245 -(% lang="en-US" %)Child welfare
246 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
247 -(% class="western" lang="en-GB" %)
248 -(% lang="en-US" %)Nursing home
249 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
250 -(% class="western" lang="en-GB" %)
251 -(% lang="en-US" %)Employment service
252 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
253 -(% class="western" %)
254 254  
255 -)))
256 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
146 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
257 257  (% class="western" lang="en-GB" %)
258 -(% lang="en-US" %)Early childhood education
259 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
260 -(% class="western" lang="en-GB" %)
261 -(% lang="en-US" %)Home care
262 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
263 -(% class="western" lang="en-GB" %)
264 264  
265 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
149 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
266 266  (% class="western" lang="en-GB" %)
267 267  
268 268  )))
269 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
270 -(% class="western" %)
271 -
272 -)))
273 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
274 -(% class="western" lang="en-GB" style="text-align:center" %)
275 -(% lang="en-US" %)**Vulnerable groups**
276 -)))
277 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="text-align:justify; vertical-align:middle" %)Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
278 278  (% class="western" lang="en-GB" %)
279 -(% lang="en-US" %)Minors/Children
280 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
281 -(% class="western" lang="en-GB" %)
282 -(% lang="en-US" %)Single parents with minor children
283 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
284 -(% class="western" lang="en-GB" %)
285 -(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence
286 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
287 -(% class="western" lang="en-GB" %)
288 -(% lang="en-US" %)Substance users
289 -
290 -(% class="western" lang="en-GB" %)
291 -(% lang="en-US" %)(drugs, alcohol)
156 +Down Syndrome
292 292  )))
293 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
158 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
294 294  (% class="western" lang="en-GB" %)
295 -(% lang="en-US" %)Disabled people
296 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
297 -(% class="western" lang="en-GB" %)
298 -(% lang="en-US" %)Victims of trafficking in human beings
299 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
300 -(% class="western" lang="en-GB" %)
301 -(% lang="en-US" %)Ethnic minorities and immigrants
302 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
303 -(% class="western" lang="en-GB" %)
304 -(% lang="en-US" %)Isolated people
160 +
305 305  )))
306 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
307 -(% class="western" lang="en-GB" %)
308 -(% lang="en-US" %)Elderly people
309 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
310 -(% class="western" lang="en-GB" %)
311 -(% lang="en-US" %)Persons with serious illnesses
312 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
313 -(% class="western" lang="en-GB" %)
314 -(% lang="en-US" %)Homeless people
315 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
316 -(% class="western" lang="en-GB" %)
317 -(% lang="en-US" %)Ex-prisoners and people with criminal background
318 -)))
319 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)(((
320 -(% class="western" lang="en-GB" %)
321 -(% lang="en-US" %)Pregnant women
322 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
323 -(% class="western" lang="en-GB" %)
324 -(% lang="en-US" %)Persons with mental disorders
325 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
326 -(% class="western" lang="en-GB" %)
162 +
163 +:
164 +:
165 +: Classification approaches of professional end users, students and organisations commonly acting as a primary study participant in a health and wellbeing living lab research project.
166 +
167 +(((
168 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
169 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Informal Caregivers**
170 +|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)Part of adults and citizens' group|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)
171 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Health Care Professionals / Formal Caregivers**
172 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Doctors|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Social workers|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapists|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Psychologists
173 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Registered nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Practical nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Physicians|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
174 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Students**
175 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Medical|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Engineering|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Computer Science|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Pedagogues
176 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)English Literature|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Nursing|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapy|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Social Services
177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Health Care Management|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
178 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Organizations**
179 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Hospitals|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Nursing homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Care homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Home care Organizations
180 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Network organizations|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Day care centers|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)
181 +
327 327  
328 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
329 -(% class="western" lang="en-GB" %)
330 -
331 331  )))
332 332  
333 333  :
334 334  
335 335  (% class="western" lang="en-GB" %)
336 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
188 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
337 337  
338 338  |**Researcher expertise**|**Brief use case description**
339 -|Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
340 -|Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)
341 -|Computer/Technology Scientists|Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity
342 -|(Clinical, social, developmental, neuro-) Psychologists|Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing
343 -|Social workers/researchers|Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society
344 -|Researchers with clinical expertise|(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g; via real life testing
345 -|Experts in UX research and assessment|Developing the process for user experience design (UXD, UED, or XD) supporting user behavior through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools
346 -|Experts in sport science|Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features
347 -|Experts in rehabilitation (physical, cognitive)|Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology
348 -|Experts in performing arts|Creative health improvement (e.g. for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance)
349 -|Business developers|Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market
350 -|Pedagogues/educators|Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab)
351 -|Experts in applied economics|Evaluating cost and performance in different healthcare processes, situations and public health
352 -|Experts in ergonomics and safety|Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards
353 -|Citizen Scientists / users as co-researchers|User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation
354 -|Biomedical researchers|Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g. for cognitive state)
355 -|Experts in accessibility Design|Validating accessible Architectonics and escape route models with VR experiment and real-life simulations
356 -|Neuroscientists|Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation)
357 -|Innovation and design management researchers|Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization
358 -|Experts in organizational studies|Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes
359 -|Data Scientists|Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations)
191 +|(% style="vertical-align:middle" %)Citizen scientists, users as co-researchers|(% style="vertical-align:middle" %)User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation.
192 +|(% style="vertical-align:middle" %)Computer, technology scientists|(% style="vertical-align:middle" %)Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity.
193 +|(% style="vertical-align:middle" %)Data scientists|(% style="vertical-align:middle" %)Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations).
194 +|(% style="vertical-align:middle" %)Rehabilitation (physical, cognitive) experts|(% style="vertical-align:middle" %)Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology.
195 +|(% style="vertical-align:middle" %)UX research and assessment experts|(% style="vertical-align:middle" %)Developing the process for user experience design (UXD, UED, or XD) supporting user behaviour through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools.
196 +|(% style="vertical-align:middle" %)Clinical expertise researchers|(% style="vertical-align:middle" %)(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g., via real life testing.
197 +|(% style="vertical-align:middle" %)Policymakers|(% style="vertical-align:middle" %)Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making.
198 +|(% style="vertical-align:middle" %)Biomedical researchers|(% style="vertical-align:middle" %)Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g., for cognitive state).
199 +|(% style="vertical-align:middle" %)Business developers|(% style="vertical-align:middle" %)Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market.
200 +|(% style="vertical-align:middle" %)Innovation and design management researchers|(% style="vertical-align:middle" %)Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization.
201 +|(% style="vertical-align:middle" %)Accessibility design experts|(% style="vertical-align:middle" %)Validating accessible architectonics and escape route models with VR experiment and real-life simulations.
202 +|(% style="vertical-align:middle" %)Ergonomics and safety experts|(% style="vertical-align:middle" %)Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards.
203 +|(% style="vertical-align:middle" %)Organizational studies experts|(% style="vertical-align:middle" %)Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes.
204 +|(% style="vertical-align:middle" %)Neuroscientists|(% style="vertical-align:middle" %)Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation).
205 +|(% style="vertical-align:middle" %)Psychologists (clinical, social, developmental, neuro)|(% style="vertical-align:middle" %)Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing.
206 +|(% style="vertical-align:middle" %)Social workers/researchers|(% style="vertical-align:middle" %)Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society.
207 +|(% style="vertical-align:middle" %)Sport science experts|(% style="vertical-align:middle" %)Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features.
208 +|(% style="vertical-align:middle" %)Communication studies experts|(% style="vertical-align:middle" %)Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab).
209 +|(% style="vertical-align:middle" %)Performing arts experts|(% style="vertical-align:middle" %)Creative health improvement (e.g., for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance).
210 +|(% style="vertical-align:middle" %)Pedagogues/educators|(% style="vertical-align:middle" %)Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab).
211 +|(% style="vertical-align:middle" %)Applied economics experts|(% style="vertical-align:middle" %)Evaluating cost and performance in different healthcare processes, situations and public health.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project